Interest and participation in the event continued to grow, and in 2010, the qualification was adjusted to include hosting multiple Sectionals, a series of events open to all athletes in order to qualify for the one of the 17 Regionals. The 17 regions had Canada and the United States divided into 12 regions, with the remaining regions roughly corresponding the five other populated continents. The attendance at the Games also outgrew the ranch in Aromas and moved the Home Depot Center (later called the StubHub Center) in Carson, California. The Games also expanded the Team Division to groups of six athletes and added a Masters Division for individual men and women 55-years-old and up.
By Jennifer Schiro, nurse practitioner and Whole30 Certified Coach This information is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. Always consult healthcare provider to determine the appropriateness of the information for your own situation. As a nurse practitioner, functional […]
So rather than a food-related reward for working so hard the last 30 days, why not reward yourself with something you’ve been wanting. This doesn’t have to be something tangible, just whatever you want. Personally, I would love to get some new clothes, food props, or go out on a (kidless) date with my husband. You get the idea, something that appeals to you but that isn’t food. We’re not dogs, we don’t need treats for good behavior.
Due to CrossFit's official partnership with Reebok, competitors at the 2015 Games were banned from wearing Nike footwear. Nike arranged for several trucks to be parked near the main entrance to the arena, which served as mobile billboards with the slogan "Don't ban our shoe, beat our shoe". The partnership also prohibits Nike from labeling its Metcon shoes as intended for CrossFit – the brand uses the term "high intensity training" instead.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”